FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

PL Stetson

Research Profile

Chemicals & Drugs

Anatomy

Procedures

Living Beings

Dogs
Rabbits

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Scott S Billecke; Dragomir I Draganov; Raymond E Counsell; PL Stetson; C Watson; C Hsu; Bert N La Du
Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters.
Dragomir I Draganov; PL Stetson; Catherine E Watson; Scott S Billecke; Bert N La Du
Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation.
W R Mancini; E R Glaze; PL Stetson; Harry S Greenberg
Sensitization of 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin cytotoxicity by 5-bromo-2'-deoxyuridine in human glioma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of PL Stetson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Scott S Billecke; Dragomir I Draganov; Raymond E Counsell; PL Stetson; C Watson; C Hsu; Bert N La Du
Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters.
Drug metabolism and disposition: the biological fate of chemicals 2000;28(11):1335-42.
2000: Dragomir I Draganov; PL Stetson; Catherine E Watson; Scott S Billecke; Bert N La Du
Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation.
The Journal of biological chemistry 2000;275(43):33435-42.
1999: W R Mancini; E R Glaze; PL Stetson; Harry S Greenberg
Sensitization of 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin cytotoxicity by 5-bromo-2'-deoxyuridine in human glioma.
The Journal of pharmacology and experimental therapeutics 1999;289(3):1404-9.
1998: Theodore S Lawrence; Alnawaz Rehemtulla; E Y Ng; M Wilson; James E Trosko; PL Stetson
Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine.
Cancer research 1998;58(12):2588-93.
1998: H Y Kuan; David E Smith; William D Ensminger; James A Knol; Susan J DeRemer; Z Yang; PL Stetson
Regional pharmacokinetics of 5-fluorouracil in dogs: role of the liver, gastrointestinal tract, and lungs.
Cancer research 1998;58(8):1688-94.
1997: Edward Domino; E K Zsigmond; V Kovacs; G Fekete; PL Stetson
A new route, jet injection for anesthetic induction in children--III. Ketamine pharmacokinetic studies.
International journal of clinical pharmacology and therapeutics 1997;35(11):527-30.
1997: C L Cheng; David E Smith; Peggy L Carver; S R Cox; Paul B Watkins; D S Blake; Carol A Kauffman; K M Meyer; Gordon L Amidon; PL Stetson
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test.
Clinical pharmacology and therapeutics 1997;61(5):531-43.
1996: H Y Kuan; David E Smith; W D Ensmiger; James A Knol; S J DeRemer; Z Yang; PL Stetson
Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
Cancer research 1996;56(20):4724-7.
1996: Theodore S Lawrence; E Y Chang; Mary A Davis; PL Stetson; William D Ensminger
Effect of irradiation on bromodeoxyuridine incorporation in human colon cancer xenografts.
International journal of radiation oncology, biology, physics 1996;34(3):617-21.
1995: James A Knol; S C Walker; John M Robertson; Z Yang; S DeRemer; PL Stetson; William D Ensminger; Theodore S Lawrence
Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion.
Cancer research 1995;55(17):3687-91.
1994: Patrick W McLaughlin; Theodore S Lawrence; H Seabury; N Nguyen; PL Stetson; Harry S Greenberg; W R Mancini
Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation.
International journal of radiation oncology, biology, physics 1994;30(3):601-7.
1994: Theodore S Lawrence; Mary A Davis; PL Stetson; Jonathan Maybaum; William D Ensminger
Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo.
Cancer research 1994;54(11):2964-8.
1994: William D Ensminger; S C Walker; PL Stetson; J G Wagner; James A Knol; Theodore S Lawrence; J C Andrews
Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridine.
Cancer research 1994;54(8):2121-4.
1993: PL Stetson; Edward Domino; J R Sneyd
Determination of plasma propofol levels using gas chromatography-mass spectrometry with selected-ion monitoring.
Journal of chromatography 1993;620(2):260-7.
1993: Patrick W McLaughlin; W R Mancini; PL Stetson; Harry S Greenberg; N Nguyen; H Seabury; D B Heidorn; Theodore S Lawrence
Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma.
International journal of radiation oncology, biology, physics 1993;26(4):637-42.
1993: David E Smith; Dean E Brenner; C A Knutsen; S J Deremer; P A Terrio; N J Johnson; PL Stetson; William D Ensminger
Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(2):277-83.
1992: Theodore S Lawrence; Mary A Davis; Jonathan Maybaum; S K Mukhopadhyay; PL Stetson; Daniel Normolle; Paul E McKeever; William D Ensminger
The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
Cancer research 1992;52(13):3698-704.
1992: Theodore S Lawrence; Mary A Davis; Jonathan Maybaum; PL Stetson; William D Ensminger
Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells.
International journal of radiation oncology, biology, physics 1992;22(3):499-503.
1991: PL Stetson; Daniel Normolle; James A Knol; N J Johnson; Z M Yang; E Sakmar; Diane M Prieskorn; P Terrio; C A Knutsen; William D Ensminger
Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
Journal of the National Cancer Institute 1991;83(22):1659-67.
1991: Theodore S Lawrence; Mary A Davis; Paul E McKeever; Jonathan Maybaum; PL Stetson; Daniel Normolle; William D Ensminger
Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
Cancer research 1991;51(15):3900-5.
1991: Jonathan Maybaum; E C Burton; DA Shelton; H W Jing; C E Dusenbury; William D Ensminger; PL Stetson
Divergent patterns of incorporation of bromodeoxyuridine and iododeoxyuridine in human colorectal tumor cell lines.
Biochemical pharmacology 1991;42(1):131-7.
1991: W R Mancini; PL Stetson; Theodore S Lawrence; J G Wagner; Harry S Greenberg; William D Ensminger
Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.
Cancer research 1991;51(3):870-4.
1990: Theodore S Lawrence; Mary A Davis; Jonathan Maybaum; PL Stetson; William D Ensminger
The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
Radiation research 1990;123(2):192-8.
1990: T J Hegarty; A F Thornton; R F Diaz; William F Chandler; William D Ensminger; Larry Junck; M A Page; Stephen S Gebarski; T W Hood; PL Stetson
Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.
International journal of radiation oncology, biology, physics 1990;19(2):421-8.
1990: Theodore S Lawrence; Mary A Davis; Jonathan Maybaum; PL Stetson; William D Ensminger
The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure.
International journal of radiation oncology, biology, physics 1990;18(6):1393-8.
1989: PL Stetson; Z M Yang; William D Ensminger
Pharmacodynamics of 5-iodo-2'-deoxyuridine in VX2 tumor-bearing rabbits.
Journal of the National Cancer Institute 1989;81(24):1925-6.
1989: James A Knol; PL Stetson; J G Wagner; N J Johnson; Z M Yang; Diane M Prieskorn; P Terrio; C A Knutsen; William D Ensminger
5-Bromo-2'-deoxyuridine incorporation into DNA in hepatic VX2 tumor-bearing rabbits.
The Journal of surgical research 1989;47(2):112-6.
1989: PL Stetson; U A Shukla; William D Ensminger
Stability of trimetrexate, a new non-classical antifolate, in infusion solutions.
Journal of chromatography 1989;464(1):163-71.
1989: J G Wagner; PL Stetson; James A Knol; J C Andrews; S Walker-Andrews; C A Knutsen; N Johnson; Diane M Prieskorn; P Terrio; Z Yang
Steady-state arterial and hepatic venous plasma concentrations of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine in animals--drugs which are subject to both splanchnic and extra-splanchnic elimination.
Selective cancer therapeutics 1989;5(4):193-203.
1989: Jonathan Maybaum; M S Hafner; E C Burton; PL Stetson; William D Ensminger; C E Rogers
Response of human HT-29 colorectal tumor cells to extended exposure to bromodeoxyuridine.
Cancer chemotherapy and pharmacology 1989;25(1):45-50.
1988: PL Stetson; Jonathan Maybaum; J G Wagner; D R Averill; I S Wollner; James A Knol; N J Johnson; Z M Yang; D Preiskorn; P Smith
Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
Cancer research 1988;48(23):6900-5.
1988: Harry S Greenberg; William F Chandler; R F Diaz; William D Ensminger; Larry Junck; M A Page; Stephen S Gebarski; Paul E McKeever; T W Hood; PL Stetson
Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.
Journal of neurosurgery 1988;69(4):500-5.
1988: A Shapira; J G Wagner; I S Wollner; Jonathan Maybaum; PL Stetson; William D Ensminger; Thomas Carey
Dynamics of bromodeoxyuridine incorporation into DNA of squamous carcinoma cells during mid and late logarithmic growth.
Pharmaceutical research 1988;5(8):518-22.
1987: I S Wollner; C A Knutsen; K A Ullrich; C E Chrisp; J E Juni; J C Andrews; M J Tuscan; PL Stetson; William D Ensminger
Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bromodeoxyuridine infusion in dogs.
Cancer research 1987;47(12):3285-90.
1986: I S Wollner; C A Knutsen; K A Ullrich; John E Niederhuber; J W Crudup; J E Juni; Sara L Warber; J Gyves; PL Stetson; William D Ensminger
A dog model using an implanted system for protracted hepatic arterial chemotherapy.
The Journal of surgical research 1986;41(5):510-7.
1986: J G Wagner; J W Gyves; PL Stetson; S C Walker-Andrews; I S Wollner; M K Cochran; William D Ensminger
Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
Cancer research 1986;46(3):1499-506.
1986: PL Stetson; Jonathan Maybaum; U A Shukla; William D Ensminger
Simultaneous determination of thymine and 5-bromouracil in DNA hydrolysates using gas chromatography-mass spectrometry with selected-ion monitoring.
Journal of chromatography 1986;375(1):1-9.
1985: PL Stetson; U A Shukla; William D Ensminger
Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma.
Journal of chromatography 1985;344():385-90.
1985: William D Ensminger; J W Gyves; PL Stetson; S Walker-Andrews
Phase I study of hepatic arterial degradable starch microspheres and mitomycin.
Cancer research 1985;45(9):4464-7.
1985: U A Shukla; PL Stetson; William D Ensminger
Rapid gas-liquid chromatographic method for plasma verapamil level determination.
Journal of chromatography 1985;342(2):406-10.
1985: PL Stetson; U A Shukla; P R Amin; William D Ensminger
High-performance liquid chromatographic method for the determination of bromodeoxyuridine and its major metabolite, bromouracil, in biological fluids.
Journal of chromatography 1985;341(1):217-22.
1984: U A Shukla; PL Stetson; J G Wagner
Sensitive gas-liquid chromatographic-electron-capture detection method for determination of sobrerol in biological fluids.
Journal of chromatography 1984;308():189-97.
1984: P B Layton; Harry S Greenberg; PL Stetson; William D Ensminger; J W Gyves
BCNU solubility and toxicity in the treatment of malignant astrocytomas.
Journal of neurosurgery 1984;60(6):1134-7.
1984: J W Gyves; William D Ensminger; PL Stetson; John E Niederhuber; M Meyer; S Walker; M A Janis; S Gilbertson
Constant intraperitoneal 5-fluorouracil infusion through a totally implanted system.
Clinical pharmacology and therapeutics 1984;35(1):83-9.
1983: J W Gyves; William D Ensminger; D VanHarken; John E Niederhuber; PL Stetson; S Walker
Improved regional selectivity of hepatic arterial mitomycin by starch microspheres.
Clinical pharmacology and therapeutics 1983;34(2):259-65.
1983: J W Gyves; PL Stetson; William D Ensminger; M Meyer; S Walker; S Gilbertson; M A Janis
Hepatic arterial streptozocin: a clinical pharmacologic study in patients with liver tumors.
Cancer drug delivery 1983;1(1):63-8.